Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

SAB Biotherapeutics (SABSW) Receivables - Other (2020 - 2021)

SAB Biotherapeutics' Receivables - Other history spans 2 years, with the latest figure at $6250.0 for Q4 2021.

  • For Q4 2021, Receivables - Other changed 0.0% year-over-year to $6250.0; the TTM value through Dec 2021 reached $6250.0, changed 0.0%, while the annual FY2021 figure was $6250.0, 0.0% changed from the prior year.
  • Receivables - Other reached $6250.0 in Q4 2021 per SABSW's latest filing, roughly flat from $6250.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $6250.0 in Q4 2020 to a low of $6250.0 in Q4 2020.